a new antidementia drug. For example, the search for Alzheimer's drug solanezumab ended in failure after spending millions on late-stage trials recently. Therefore, it is pretty necessary to reassess a promising current drug to halt the progressive cognitive dysfunctions with an established safety profile for AD.
Neurotropin
® (NTP), a nonprotein extract from inflamed rabbit skin inoculated with vaccinia virus, is a well-known analgesic drug for treatment of chronic pain, such as low back pain, postherpetic neuralgia, neck-shoulder-arm syndrome, hyperesthesia of subacute myelo-optic neuropathy (SMON), and fibromyalgia. [2] [3] [4] [5] Recently, it is reported that NTP-stimulated BDNF expression in SH-SY5Y cells, and repeated oral administration of NTP (200 NU/kg/d for 3 months) inhibited the decline of hippocampal BDNF expression, accompanied by improvement in spatial cognition of Ts65Dn mice, a model of Down syndrome. 6 Furthermore, Nakajo et al. 7 demonstrated that chronic NTP treatment reduced the volumes of infracted lesions, brain edema, and the extent of the neurological deficits, and also enhanced spatial learning of C57BL/6J mice. A pilot study for clinical applications of NTP had shown that NTP was capable of improving clinical symptoms of senile patients with dementia. 8 Besides, it is found by Hoshino et al. 9 that NTP demonstrated cytoprotective effects against hydrogen peroxide and cigarette smoke through elevating the expression of redox-regulating molecules, glutathione peroxidase, and catalase and, especially, thioredoxin-1. NTP also increased the cellular thioredoxin-1 content and regulated thioredoxin-1 release from cells, suppressing intracellular oxidative activity. Nevertheless, the potential antioxidative effect of NTP against neuronal damage remains to be determined. Besides, oxidative stress plays a crucial role in the pathogenetic mechanism for AD. Thus, we investigated the antioxidative capabilities of NTP on HT22 cells and APP/PS1 mice to obtain evidence for the administration of NTP for the treatment of AD.
In this study, we used immortalized murine hippocampal neurons (HT22 cells) as a cell model to explore whether NTP had potential capability to alleviate Aβ 25-35 -induced neuronal damage. As reported, Aβ [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] is the shortest active fragment with similar neurotoxicity effect to a full-length Aβ. 10 In addition, Aβ [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] can be easily synthesized and has been widely used in scientific researches. [11] [12] [13] Thus, we choose this fragment in our research. In vivo, we examined the alterations of the activities of antioxidants and Aβ deposition in hippocampus of APP/PS1 mice after administration of NTP and further investigated the potential underlying mechanisms.
| MATERIALS AND METHODS

| Materials
Neurotropin ® was provided from Nippon Zoki Pharmaceutical Co.Ltd.
(Osaka, Japan). Aβ [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] 
| Cell culture, differentiation, Aβ 25-35 preparation, and treatment
The methods used for the culture and differentiation of HT22 cells have been previously described in detail. 14, 15 Briefly, HT22 cells were cultured in DMEM media supplemented with 10% FBS, 100 U/mL penicillin, and 100 μg/mL streptomycin, and differentiated in neurobasal medium with N2 supplement for 24 hours before treatment.
Aβ [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] was diluted in sterile saline at a concentration of 0.5 mmol/L and was maintained at 37°C for 7 days to preage the peptide.
According to our previous study, 13 
| Cytotoxicity assays
A CCK-8 assay was applied to assess the viabilities of HT22 cells.
Briefly, following different treatment interventions, 10 μL/well of CCK-8 reagent was added to the cells, after which HT22 cells were incubated for 1.5 hours at 37°C and 5% CO 2 in dark conditions.
Absorbance of the samples was detected at 450 nm with a multifunctional microplate reader (SpectraMax M5, Sunnyvale, CA, USA).
| Apoptosis assay by flow cytometry (FCM)
Apoptotic cell death of HT22 cells was measured by flow cytometric analysis with annexin V-FITC and PI apoptosis detection kit as detailed previously. 15 Briefly, HT22 cells were washed twice using phosphate- 
| Measurement of intracellular ROS generation
| Estimation of the mitochondrial membrane potential (MMP, △Ψm t )
MMP was estimated using a mitochondrial membrane potential assay kit with JC-1 according to the manufacturer's instructions.
After treated, cells were washed twice with PBS and then stained with 5 μL/mL JC-1 for 20 minutes at 37°C. After two rinses with JC-1 staining buffer, the cell suspension was collected, and MMP was monitored using a flow cytometer. Approximately 10 000 events from each sample were used for flow cytometric analysis.
| Animals and drug administration
Six-month-old male APP/PS1 transgenic mice were obtained from Jackson Laboratory (Bar Harbor, ME, USA) and were maintained with free access to food and water. All mice used in this study were han- 
| Measurements of SOD, MDA, GSH, and CAT
The activities of superoxide dismutase (SOD), glutathione (GSH), and catalase (CAT), as well as the contents of malondialdehyde (MDA)
were determined using the commercial kits according to the manufacturer's instructions. The tissues of hippocampus were homogenized by sonication in cold 0.9% NaCl (9 mL), centrifuged at 4000 g for 10 minutes at 4°C, and the supernatants were collected and stored at 80°C for the subsequent analysis. Protein concentration in the supernatant was assessed using micro BCA protein assay kit.
| Bielschowsky silver staining and immunohistochemistry
Bielschowsky silver staining was performed on fixed sections using the previously published method. 17, 18 For immunohistochemical stain- 
| Western blot analysis
| Statistical analysis
All data were expressed as mean±SE, and all statistical analyses were carried out using the SPSS 16.0 software (SPSS Inc., Chicago, IL, USA). One-way analysis of variance (ANOVA) with post hoc tests was used between groups, and differences between groups were compared using Student's t test. Differences were considered statistically significant at P<.05. 
| RESULTS
| In vitro neuroprotection by neurotropin
| In vitro neurotropin ® regulation of HIF-1α and apoptosis-related molecules
To further explore the mechanism of the neuroprotective capacity of NTP against Aβ 25-35 in HT22 cells, we then measured the protein expression of HIF-1α, Bcl-2, and Bax. As shown in Figure 4E , Western blot analysis revealed that NTP significantly enhanced the expression of Bcl-2. In contrast to Bcl-2 induction, NTP suppressed the expression of HIF-1α and Bax (P<.01). 
| In vivo antioxidative effect by neurotropin
| In vivo neurotropin ® inhibition of aβ deposition in hippocampus
To investigate the potential effect of NTP treatment on Aβ deposition in hippocampus of APP/PS1 mice, the coronal sections of hippocampus of control wide-type mice, control, and NTP-treated APP/PS1 mice were determined using Bielschowsky silver staining, and hippocampal tissues were collected for the measure- Central nervous system is particularly vulnerable to oxidative damage known as oxidative stress due to the relatively high oxygen consumption, metal cations, and lipid concentrations, but low levels of cellular antioxidants. 20 Growing evidence indicated that in the process of aging and neurodegenerative diseases, abnormal antioxidant defense mechanisms increased oxidative damage to the brain. 21 It is reported that ROS were capable to modify crucial molecules involved in neurodegenerative diseases. In healthy cells, ROS are byproducts of oxidative phosphorylation in the mitochondria's electron transport chain, and there are several endogenous antioxidant molecules existing for the modulation of oxidative balance, including SOD, CAT, and GSH. These antioxidants can coordinate to facilitate the dismutation of superoxide into oxygen and water to effectively mitigate ROS damage. [23] [24] [25] However, when ROS levels break the protection of endogenous antioxidants or antioxidants are oxidized by ROS in persistence, homeostasis becomes hard to maintain, which can promote mitochondrial membrane permeability, activate cell death signals and other disorders in cells. 26 In AD, one possible vehicle for Aβ plaque formation is ROS production, due to either mitochondrial dysfunction, age, or both. 27 Reduced antioxidant activity is a hallmark of AD, and it is found that the activities of antioxidants were markedly reduced in AD brains, which could even result in the formation of Aβ plaques.
| DISCUSSION
28,29
Accumulating evidence indicates that hypoxia inducible factor-1α
(HIF-1α) is essential for cellular oxygen balance. Under physiological conditions, HIF-1α levels are low but increase dramatically under hypoxia. It has been found that an upregulation of HIF-1α enhanced expression of BACE1, while the HIF-1α knock-out mouse demonstrated a downregulation in BACE1 expression in hippocampus. 30 Recently, NTP is likely to be associated with the suppression of HIF-1α and MAPK signaling pathways. In brief, NTP may act as a radical scavenger to be applied for the prevention and treatment of AD in the future. However, the optimal concentration of NTP is crucial for therapeutic use, and further investigation is warranted for the determination of appropriate dose.
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